How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing

Basit Öğe Kaydı
dc.contributor.authorMoulahoum, H.
dc.contributor.authorGhorbanizamani, F.
dc.contributor.authorZihnioglu, F.
dc.contributor.authorTurhan, K.
dc.contributor.authorTimur, S.
dc.date.accessioned2020-12-01T11:52:16Z
dc.date.available2020-12-01T11:52:16Z
dc.date.issued2021
dc.departmentEge Üniversitesien_US
dc.description.abstractAs COVID-19 has reached pandemic status and the number of cases continues to grow, widespread availability of diagnostic testing is critical in helping identify and control the emergence of this rapidly spreading and serious illness. However, a lacking in making a quick reaction to the threat and starting early development of diagnostic sensing tools has had an important impact globally. In this regard, here we will review critically the current developed diagnostic tools in response to the COVID-19 pandemic and compare the different types through the discussion of their pros and cons such as nucleic acid detection tests (including PCR and CRISPR), antibody and protein-based diagnosis tests. In addition, potential technologies that are under development such as on-site diagnosis platforms, lateral flow, and portable PCR units are discussed. Data collection and epidemiological analysis could also be an interesting factor to incorporate with the emerging technologies especially with the wide access to smartphones. Lastly, a SWOT analysis and perspectives on how the development of novel sensory platforms should be treated by the different decision-makers are analyzed. © 2020 Elsevier B.V.en_US
dc.description.sponsorshipThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Authors thank Dr. Korhan Ege for the fruitful discussions.en_US
dc.identifier.doi10.1016/j.talanta.2020.121534en_US
dc.identifier.issn0039-9140
dc.identifier.pmid33167242en_US
dc.identifier.scopus2-s2.0-85089373920en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.1016/j.talanta.2020.121534
dc.identifier.urihttps://hdl.handle.net/11454/61481
dc.identifier.volume222en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofTalantaen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectDiagnostic kitsen_US
dc.subjectResponse strategiesen_US
dc.subjectSARS-CoV-2en_US
dc.subjectSensors/biosensorsen_US
dc.titleHow should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensingen_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu